Integrated multi-omics, machine learning, network toxicology, and molecular docking reveal potential mechanisms underlying methyl 4-hydroxybenzoate-associated breast cancer.
Medicine
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.